Evidence map›Paper›PMID 19220063›Full record

ArticleBiochemistry2009

Evolution of enzymatic activities in the enolase superfamily: stereochemically distinct mechanisms in two families of cis,cis-muconate lactonizing enzymes.

Ayano Sakai, Alexander A Fedorov, Elena V Fedorov, Alexandra M Schnoes, Margaret E Glasner, Shoshana Brown, Marc E Rutter, Kevin Bain, Shawn Chang, Tarun Gheyi and 5 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Biochemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Evaluating Functional Annotations of Enzymes Using the Gene Ontology.Methods in molecular biology (Clifton, N.J.) · 2017
    Article
  7. Article
  8. Review
  9. Review
  10. Loss of quaternary structure is associated with rapid sequence divergence in the OSBS family.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Ayano SakaiCenter for Biophysics and Computational Biology, University of Illinois, Urbana, Illinois 61801, USA.
Alexander A Fedorov
Elena V Fedorov
Alexandra M Schnoes
Margaret E Glasner
Shoshana Brown
Marc E Rutter
Kevin Bain
Shawn Chang
Tarun Gheyi
J Michael Sauder
Stephen K Burley
Patricia C Babbitt
Steven C Almo
John A Gerlt
Albert Einstein College of Medicine · US

Funding

SUBPROJECT 5U54GM074945 · NIGMS · SGX PHARMACEUTICALS, INC. · PI BURLEY, STEPHEN KEVIN · 2005 to 2009
$46.2M
XRAY CRYSTALLOGRAPHIC STRUCTURE ANALYSIS: PROTEIN SORTINGP41RR001081 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 1985 to 2011
$17.6M
Theoretical and Computational ApproachesP01GM071790 · NIGMS · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI RAUSHEL, FRANK M. · 2004 to 2013
$15.5M
Laying the Foundation of Genomic EnzymologyR01GM060595 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BABBITT, PATRICIA CLEMENT · 2000 to 2018
$5.4M
NCRR NIH HHS P41 RR001081NCRR NIH HHS P41 RR-01081NIGMS NIH HHS P01 GM071790NIGMS NIH HHS P01 GM-71790NIGMS NIH HHS R01 GM060595NIGMS NIH HHS R01 GM-60595NIGMS NIH HHS U54 GM074945NIGMS NIH HHS U54 GM-74945
6 · The paper itself

Abstract

The mechanistically diverse enolase superfamily is a paradigm for elucidating Nature's strategies for divergent evolution of enzyme function. Each of the different reactions catalyzed by members of the superfamily is initiated by abstraction of the alpha-proton of a carboxylate substrate that is coordinated to an essential Mg(2+). The muconate lactonizing enzyme (MLE) from Pseudomonas putida, a member of a family that catalyzes the syn-cycloisomerization of cis,cis-muconate to (4S)-muconolactone in the beta-ketoadipate pathway, has provided critical insights into the structural bases for evolution of function within the superfamily. A second, divergent family of homologous MLEs that catalyzes anti-cycloisomerization has been identified. Structures of members of both families liganded with the common (4S)-muconolactone product (syn, Pseudomonas fluorescens, gi 70731221 ; anti, Mycobacterium smegmatis, gi 118470554 ) document that the conserved Lys at the end of the second beta-strand in the (beta/alpha)(7)beta-barrel domain serves as the acid catalyst in both reactions. The different stereochemical courses (syn and anti) result from different structural strategies for determining substrate specificity: although the distal carboxylate group of the cis,cis-muconate substrate attacks the same face of the proximal double bond, opposite faces of the resulting enolate anion intermediate are presented to the conserved Lys acid catalyst. The discovery of two families of homologous, but stereochemically distinct, MLEs likely provides an example of "pseudoconvergent" evolution of the same function from different homologous progenitors within the enolase superfamily, in which different spatial arrangements of active site functional groups and substrate specificity determinants support catalysis of the same reaction.

Indexed as

Evolution, MolecularBiocatalysisCloning, MolecularCrystallography, X-RayIntramolecular LyasesModels, MolecularMycobacterium smegmatisPhosphopyruvate HydratasePhylogenyProtein ConformationPseudomonas fluorescensPseudomonas putidaStereoisomerismSubstrate SpecificityIntramolecular Lyasesmuconate cycloisomerasePhosphopyruvate Hydratase

Identifiers

PMID19220063
PMCPMC2746992
OpenAlexW2058189144

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.